Synthomer (LON:SYNT) Given New GBX 230 Price Target at Berenberg Bank

Synthomer (LON:SYNTGet Free Report) had its price objective dropped by investment analysts at Berenberg Bank from GBX 265 ($3.31) to GBX 230 ($2.87) in a research note issued on Monday, MarketBeat.com reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s target price would indicate a potential upside of 64.29% from the stock’s current price.

Separately, Canaccord Genuity Group reduced their price target on shares of Synthomer from GBX 300 ($3.74) to GBX 275 ($3.43) and set a “buy” rating for the company in a research report on Friday, October 4th.

Get Our Latest Research Report on SYNT

Synthomer Trading Down 7.5 %

Synthomer stock opened at GBX 140 ($1.75) on Monday. Synthomer has a 12 month low of GBX 118 ($1.47) and a 12 month high of GBX 338 ($4.22). The business’s fifty day simple moving average is GBX 168.03 and its two-hundred day simple moving average is GBX 210.77. The company has a market capitalization of £229.00 million, a price-to-earnings ratio of -229.51, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 77.42.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Recommended Stories

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.